We are live on ! Find out more

Small Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
LKFT icon
1
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
$1.96B $29.90 0.1%
PHVS icon
2
Pharvaris
PHVS
$1.95B
$1.95B $27.74 6.41%
IMNM icon
3
Immunome
IMNM
$1.94B
$1.94B $16.47 5.34%
ADRX icon
4
ADARx Pharmaceuticals, Inc. Common Stock
ADRX
$1.89B
$1.89B $17.65 0.28%
AGIO icon
5
Agios Pharmaceuticals
AGIO
$1.87B
$1.87B $31.32 3.09%
NVAX icon
6
Novavax
NVAX
$1.86B
$1.86B $11.26 12.2%
RXRX icon
7
Recursion Pharmaceuticals
RXRX
$1.86B
$1.86B $3.46 16.8%
SRPT icon
8
Sarepta Therapeutics
SRPT
$1.81B
$1.81B $17.10 3.88%
ZYME icon
9
Zymeworks
ZYME
$1.8B
$1.8B $25.03 2.8%
MLYS icon
10
Mineralys Therapeutics
MLYS
$1.79B
$1.79B $20.30 6.19%
PVLA icon
11
Palvella Therapeutics
PVLA
$1.73B
$1.73B $120.30 5.53%
MESO icon
12
Mesoblast
MESO
$1.72B
$1.72B $13.28 4.8%
XNCR icon
13
Xencor
XNCR
$1.7B
$1.7B $22.85 4.79%
SEPN icon
14
Septerna Inc
SEPN
$1.7B
$1.7B $36.35 2.94%
TRVI icon
15
Trevi Therapeutics
TRVI
$1.69B
$1.69B $11.88 1.9%
URGN icon
16
UroGen Pharma
URGN
$1.69B
$1.69B $34.56 5.6%
VIR icon
17
Vir Biotechnology
VIR
$1.69B
$1.69B $9.96 4.87%
BRVE
18
Braveheart Bio
BRVE
$1.68B
$1.68B $18.71 4.3%
BHVN icon
19
Biohaven
BHVN
$1.63B
$1.63B $10.78 5.69%
ZBIO icon
20
Zenas BioPharma
ZBIO
$1.62B
$1.62B $24.84 2.2%
NTLA icon
21
Intellia Therapeutics
NTLA
$1.6B
$1.6B $11.42 0.71%
NUVB icon
22
Nuvation Bio
NUVB
$1.56B
$1.56B $4.45 6.32%
STOK icon
23
Stoke Therapeutics
STOK
$1.56B
$1.56B $24.17 1.79%
GENB icon
24
Generate Biomedicines
GENB
$1.55B
$1.55B $12.09 7.43%
MAZE icon
25
Maze Therapeutics
MAZE
$1.53B
$1.53B $27.53 0.18%
1
2 3 4 5

Small Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 178 small cap Biotechnology stocks — companies in the Biotechnology industry with a market cap between $250M and $2B — worth a combined $151B.

The largest by market cap are Lakefront Biotherapeutics American Depositary Shares (LKFT) at $1.96B, Pharvaris (PHVS) at $1.95B and Immunome (IMNM) at $1.94B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.